What is Anemia?
Anemia means the hemoglobin level is lower than normal, reflecting a drop in the number or function of red blood cells, so less oxygen reaches the tissues. It affects up to one-third of the global population. You confirm and quantify it with the RBC count, hemoglobin, and hematocrit.
Classify it by the corrected reticulocyte count. Hypoproliferative anemia (reticulocyte count <2%) splits by mean corpuscular volume into microcytic (MCV <80 fl), normocytic (MCV 80 to 100 fl), and macrocytic (MCV >100 fl). Hyperproliferative anemia is a corrected reticulocyte count >2%.
The dangerous complications come from tissue hypoxia: shock, hypotension, and coronary or pulmonary insufficiency, mostly in older adults with underlying heart or lung disease.
Nursing Care Plans & Management
Priorities for the anemic patient: correct inadequate oxygenation, manage fatigue and activity intolerance, find and treat nutritional deficiencies, give medications safely, monitor transfusions, and teach self-care.
Nursing Assessment
Assess for the following subjective and objective data:
- Exertional dyspnea or discomfort, and inability to maintain usual activity
- Reports of fatigue, lack of energy, and increased rest requirements
- Abnormal heart rate or BP response to activity, generalized weakness, deconditioning
- Changes in vital signs, diminished peripheral pulses, delayed capillary refill
- General pallor, decreased mentation, restlessness, palpitations
- Tingling in extremities, intermittent claudication, delayed wound healing
- Questioning or inaccurate follow-through on instructions (knowledge gaps)
Factors related to the cause:
- Decreased hemoglobin and reduced oxygen-carrying capacity
- Imbalance between oxygen supply and demand, reduced energy stores
- Bone marrow malfunction, marrow replacement with fat (aplastic anemia)
- Vaso-occlusive sickling (sickle cell anemia), inflammatory response
- New condition, unfamiliarity with the disease, lack of recall or resources
Nursing Goals
Goals and expected outcomes may include:
- The client will verbalize understanding of energy conservation and report reduced fatigue with increased ability to do desired activities.
- The client will identify factors that aggravate activity intolerance and methods to reduce it, and perform required ADLs.
- The client will verbalize understanding of the disease process, diagnostic procedures, complications, and treatment plan, and initiate needed lifestyle changes.
- The client will have a reduced risk of infection (no fever, normal WBC count, good hand hygiene) and vital signs within normal limits.
- The client will have a reduced risk for bleeding (adequate platelet levels, no bruises or petechiae).
- The client will show improved tissue perfusion (stable vital signs, strong peripheral pulses, adequate urine output), usual mentation, normal capillary refill, warm dry skin, pink nailbeds and lips, and no paresthesias.
Nursing Interventions and Actions
1. Improving Activity Tolerance and Managing Fatigue
Acute blood loss or severe hemolysis drops the circulating red cell mass, and fatigue is the most common and most underrated symptom of anemia. Patients describe it as overwhelming even when the anemia is not severe enough to transfuse, and it limits work, family life, and self-care. Take it seriously.
1. Assess for activity intolerance and have the client rate perceived exertion on a 0-10 scale. Dyspnea on exertion, headache, dizziness, palpitations, and a rating above 3 signal intolerance and decreased tissue oxygenation. Have the client stop or scale back the activity until those signs resolve. The Borg Rating of Perceived Exertion tracks intensity by the physical sensations the client feels: faster heart rate, faster breathing, sweating, and muscle fatigue.
2. Assess the specific cause of fatigue. The usual driver is tissue hypoxia from anemia, but other comorbidities also limit tolerance. Minimum hemoglobin during hospitalization correlates with fatigue in patients over 50, especially those without sickle cell disease or GI bleeding.
3. Assess ability to perform ADLs and the demands of daily living. Fatigue limits self-care and role function at home and work. Anemia carries a real public health cost: in 2010 it accounted for 68.4 million years lived with disability, about 9% of the global disability burden.
4. Assess fall risk and put precautions in place. Anemia often progresses slowly, so clients underestimate their own weakness. About 17% of people 65 and older are anemic, which raises their fall risk. Failure to monitor leads to injury and longer stays.
5. Assess the emotional response to activity limits. Loss of function is a source of frustration and depression. Even one session of moderate activity lowers anxiety, and short bouts still help.
6. Evaluate mobility with a timed up-and-go test (TUG). The TUG screens for sarcopenia, the loss of muscle mass and function seen in roughly 10% of healthy older adults. Time the client rising from an armchair, walking 3 meters, turning, walking back, and sitting down.
7. Monitor pulse oximetry and give supplemental oxygen for an O2 saturation of 92% or less. Oxygen delivery depends on arterial oxygen content and cardiac output; supplemental oxygen supports delivery when saturation drops.
8. Monitor hemoglobin, hematocrit, RBC count, and reticulocyte count. Falling indices mean falling oxygen-carrying capacity. Trend serial values to catch deterioration before it becomes life-threatening. The WHO 2024 guideline defines anemia in adults as a hemoglobin under 13 g/dL in men and under 12 g/dL in non-pregnant women; some US lab references set slightly different cutoffs, such as below 13.5 g/dL in males and below 12.5 g/dL in females.
9. Encourage deep breathing and give oxygen as prescribed. These boost oxygen delivery. The body compensates for anemia mainly by raising cardiac output as systemic vascular resistance falls.
10. Build a schedule that balances activity with frequent rest. Energy reserves deplete unless the client rests. Pacing lets the client finish what matters without piling on fatigue. With severe anemia, curtail activity until it is partially corrected; bedrest while therapy starts can often spare a transfusion in correctable anemia such as pernicious anemia.
11. Let the client verbalize feelings about the limitations. Acknowledging that activity intolerance is hard, physically and emotionally, helps the client cope. Moderate activity also improves cognition and lowers short-term anxiety.
12. Teach energy-conservation techniques. Delegating tasks, setting priorities, and clustering care stretch limited energy. Suggest showering seated and sitting for tasks so the client stays active without exhausting reserves.
13. Increase activity gradually as strength returns. This builds endurance and prevents the problems of prolonged bedrest. Rhythmic, repetitive aerobic activity using large muscle groups, in short moderate-intensity intervals several times a week, gives the best physical and psychological benefit.
14. Protect blocks of undisturbed rest. Fewer interruptions let the client benefit from sleep until the anemia resolves.
15. Encourage physical exercise as tolerated. In cancer patients with anemia, exercise during and after treatment is safe and reduces fatigue, improves fitness, and improves quality of life. Aerobic exercise has the clearest benefit; resistance training is less well established.
16. Teach the client about medications that stimulate RBC production. Recombinant human erythropoietin (rHuEPO) raises hemoglobin and cuts transfusion need. Some clients on repeated rHuEPO develop neutralizing antibodies and pure red cell aplasia (PRCA).
17. Anticipate transfusion of packed RBCs. Packed RBCs raise oxygen-carrying capacity and are the primary treatment for symptomatic anemia in hospitalized clients.
18. Watch for transfusion reactions and confirm type and crossmatch. Verifying type and crossmatch prevents giving the wrong blood. Clients with autoimmune antibodies against RBCs are harder to crossmatch and at higher risk for hemolytic reaction; occasionally their blood cannot be crossmatched in vitro and requires slow in-vivo crossmatching with monitoring for hemoglobinemia.
19. Administer packed RBCs or erythropoietin replacement (recombinant EPO, epoetin-alfa). Typical dosing is 150 units/kg IV three times weekly, 600 units/kg subcutaneously once weekly, or darbepoetin alfa 200 mcg every 2 weeks. Reserve PRBC transfusion for clients who are actively bleeding or severely symptomatic; it is palliative and not a substitute for specific therapy. EPO helps avert or reduce transfusions in anemia of chronic disease.
20. Administer iron, cobalamin, and folate as indicated. These restore hemoglobin and replete deficient stores. For blood-loss anemia, correct the underlying cause and give oral ferrous sulfate until the anemia resolves. Pyridoxine may help in some sideroblastic anemias. A strict vegetarian diet requires iron and vitamin B12 supplementation.
21. Teach dietary improvement. Better intake reduces symptoms. Heme iron from meat is absorbed more efficiently than non-heme iron from plants, which matters where little meat is eaten.
22. Provide nutrition adequate to the client's needs. Nutritional therapy treats iron, vitamin B12, and folic acid deficiencies. Teach iron-rich foods: green leafy vegetables, tofu, red meat, raisins, and dates.
23. Offer alternative fatigue relief such as acupressure and yoga. Acupressure stimulates specific acupoints and triggers a relaxation response; yoga can produce invigorating effects similar to aerobic exercise and reduce fatigue. For cancer patients with anemia, keep yoga gentle and get oncology clearance first.
24. Document the response to activity. This guides safe progression. Have the client self-monitor with the Borg scale and keep an activity diary at home.
25. Teach pregnant clients why physical activity matters. Inactivity slows metabolism and iron metabolism, reducing hemoglobin formation and oxygen transport. Pregnancy already raises metabolic demand from the maternal tissues, fetus, and placenta, and strenuous activity worsens maternal anemia, so balance is the message.
26. Refer to occupational therapy. OT teaches assistive-device use and helps the client and family set up energy-conservation measures at home.
2. Patient Education and Health Teaching
Anemia stays one of the most common diseases worldwide, and health education is one of the WHO-recommended strategies to prevent and control it. Teaching improves knowledge, adherence, and prevalence, especially among adolescent girls, pregnant women, and preschool children.
1. Assess current knowledge of the diagnosis, disease process, causes, and treatment. This shapes individualized teaching. Many clients understand iron-deficiency anemia but not other types, so cover the etiology, significance, and treatment options for their specific anemia.
2. Assess the client's and family's grasp of medical vocabulary. Most people have limited exposure to clinical language. Gaps in knowledge, education, and nutrition contribute to iron deficiency, particularly in adolescent females.
3. Assess resources, including finances and the ability to obtain and prepare food. Limited resources affect access to appropriate foods. Animal-source foods close nutrient gaps but are expensive, and many low-income and rural households cannot afford them.
4. Explain the diagnostic workup: complete blood count, bone marrow aspiration, and possible hematology referral. Diagnosis rests on RBC indices and marrow findings. Reliable testing keeps important clues from being missed and spares clients unnecessary tests and treatment.
5. Explain the blood elements and their functions: white cells, red cells, and platelets. Anemia is a decreased number of RBCs measured by hemoglobin, hematocrit, and RBC count. Iron-deficiency anemia occurs when there is too little iron to make hemoglobin.
6. Teach the client to avoid known risk factors. Alcohol, toxic chemicals, dietary deficiencies, and certain medications impair RBC production. There are only three causes of anemia: blood loss, increased RBC destruction, and decreased RBC production, and each requires specific therapy.
For clients with aplastic anemia:
7. Explain that transfusions from prospective marrow donors should be avoided. They can sensitize the client against non-HLA tissue antigens and lead to donor marrow rejection. Guide transfusion by clinical status, not numbers alone.
8. Explain the need for rapid HLA typing. HLA typing (tissue typing) identifies antigens on white cells that determine transplant compatibility. Test early to find related donors, especially for young clients, because prior transfusion burden significantly affects transplant outcomes.
9. Explain that immunosuppressive therapy is first-line in clients without an HLA-matched donor or older than 40. It uses granulocyte-macrophage colony-stimulating factors, cyclophosphamide, anti-thymocyte globulin, and cyclosporine, with an overall response rate of 60 to 80% and a 5-year survival around 75%, though event-free survival runs 35 to 50%.
10. Explain that allogeneic hematopoietic stem cell transplantation (HCT) is standard for clients under 40 with HLA-identical related donors. A major problem in aplastic anemia is the high rejection rate, which rises with the number of prior transfusions and longer disease duration before transplant.
11. Explain the complications of immunosuppressive therapy:
- 11.1. Acute graft-versus-host disease (GVHD). Early signs include a red maculopapular rash, dry eyes, abdominal pain, and jaundice. Acute GVHD is dermatitis, hepatitis, and enteritis developing within 100 days of allogeneic transplant.
- 11.2. Chronic GVHD. Skin rash and mouth sores are common first signs; the rash is often slightly raised and itchy. Chronic GVHD develops after day 100, either extending acute GVHD or arising de novo.
- 11.3. Rejection of donor marrow. Sensitization from prior transfusions drives rejection and carries a high mortality rate. Cyclophosphamide (Cytoxan) plus total lymphoid irradiation lowers the risk of graft failure; high-dose cyclophosphamide stays limited to trials and has been linked to paroxysmal nocturnal hemoglobinuria (PNH) on followup.
For clients with nutritional-deficiency anemia:
12. Explain vitamin B12 replacement. Cyanocobalamin injections treat B12 deficiency caused by lack of intrinsic factor and are given monthly for life. Microbes synthesize B12, but humans and plants do not.
13. Teach foods rich in iron, folic acid, and vitamin B12. A balanced diet across food groups supplies what RBC formation needs: dark-green leafy vegetables and animal products including fish, meat, poultry, eggs, and milk. Vegan and vegetarian clients should use B12-fortified plant and soy products.
14. Teach replacement therapy with folic acid and iron. Dose and frequency depend on severity. Give oral iron with meals to limit gastric upset, or IM by Z-track to prevent subcutaneous leakage. Give folic acid orally with a full glass of water. Vitamin C improves iron absorption; excess tea or coffee reduces it.
For blood-loss anemia:
15. Teach the client about medications that stimulate RBC production. Recombinant human erythropoietin raises hemoglobin and reduces transfusion need in clients who cannot make enough endogenous erythropoietin, and it improves quality of life.
16. Explain that packed RBC transfusion may be needed. One unit of packed RBCs raises hemoglobin by about 1 g/dL. Reserve it for active bleeding or severe symptomatic anemia; it is palliative, not a substitute for specific therapy, and carries risks of hemolytic reaction and infection transmission.
17. Reinforce information about splenectomy when indicated. Splenectomy helps in autoimmune hemolytic anemias and some hereditary hemolytic disorders, though it is not first-line in aplastic anemia. Immunize with the polyvalent pneumococcal vaccine more than one week before surgery.
18. Teach pregnant clients about iron-rich food choices. Dietary teaching improves the ability to choose foods rich in iron, protein, and vitamin C, which raises hemoglobin.
19. Encourage smoking cessation. Smoking lowers available oxygen and causes vasoconstriction. Tobacco use raises iron-deficiency risk by affecting iron metabolism and stores and by suppressing appetite and food intake; green leafy vegetables lower the risk.
3. Preventing Infection
Anemia is a known risk factor for recurrent infection, and the picture is worst in immunocompromised patients such as those with aplastic anemia or on immunosuppression. Adequate iron supports the proliferation and maturation of immune cells, particularly lymphocytes.
1. Assess for local and systemic signs of infection: fever, chills, swelling, pain, malaise. Opportunistic infection develops easily in immunocompromised clients, and infection, neoplasm, or collagen vascular disease can itself cause anemia.
2. Monitor the WBC count. Leukopenia (generally under 4,000 white cells per microliter in adults) lowers disease-fighting capacity. Neutropenia, an abnormal drop in neutrophils, can be congenital or secondary to B12 and folate deficiency or marrow depression.
3. Have the client report signs and symptoms of infection immediately. Even a simple fever or chills can signal infection and may indicate a need for antibiotics. With marrow suppression, leukocyte failure can lead to fulminating infection.
4. Anticipate antibiotic, antiviral, and antifungal therapy. Antibacterial prophylaxis against gram-negative bacilli, especially a fluoroquinolone, is recommended when profound neutropenia is expected for more than seven days after chemotherapy. Invasive fungal infections are common in aplastic anemia.
5. Teach the client to avoid people with active infections. Others are a source of infection for the immunocompromised client. Children 12 and younger are frequent carriers, especially of upper respiratory infections. Protective isolation may be needed when immune responses are most compromised.
6. Provide a private room for protective isolation when hospitalized. Consider it when the absolute neutrophil count is below 500/mm3. Precautions include a private room, limited visitors, and masks, gowns, and gloves for everyone in contact.
7. Have the client avoid raw fruits, vegetables, and uncooked meat. A low-bacterial diet limits exposure to pathogens. For neutropenic or immunosuppressed clients with aplastic anemia, exclude raw meats, dairy, and produce likely colonized by bacteria, fungus, or mold.
8. Stress daily hygiene, mouth care, and perineal care. These prevent skin breakdown and lower infection risk. Increase toothbrushing frequency in high-caries clients, such as those with xerostomia in Fanconi anemia.
9. Teach the client and visitors proper handwashing. Hand hygiene is the most effective way to prevent infection. Use alcohol-based rub or soap and water before touching clients with aplastic anemia.
10. Limit visitors and staff and bar fresh plants or fruit. This cuts exposure to infectious agents. Anyone with a cough, cold, or upper respiratory infection should stay away. Live flowers carry fungal spores and should not enter the room.
11. Handle IV lines and catheters aseptically. These clients need repeated venipuncture for transfusions and IV antibiotics, and indwelling lines are a critical infection source if not handled carefully.
12. Give WBC growth factor to stimulate neutrophil production. Colony-stimulating factors such as pegfilgrastim and filgrastim stimulate infection-fighting white cells. Weigh cytokine support against cost and efficacy in refractory infection.
13. Give antibiotics or antivirals as prescribed. Clients on immunosuppression should get prophylactic antiviral therapy. Empiric antibiotics should be broad, covering gram-negatives and staphylococci by local sensitivities, with anti-pseudomonal coverage at the start of treatment for febrile neutropenia.
4. Preventing Bleeding and Improving Tissue Perfusion
Anemia raises bleeding risk and starves tissues of oxygen, and in sickle cell disease vaso-occlusion adds infarction and pain. Watch the platelet count, look for occult and frank bleeding, and protect perfusion.
1. Assess the skin for bruises and petechiae. These appear as the platelet count drops toward 20,000 mm3. Purpura, ecchymoses, and petechiae suggest thrombocytopenia or another bleeding disorder, and may mean more than one marrow lineage is involved or coagulopathy is causing the anemia.
2. Monitor vital signs closely and assess pulses for rate, rhythm, and volume. In sickle cell disease, sludging and sickling in peripheral vessels reduce perfusion, and sudden massive splenic sequestration can cause shock. Children with sickle cell anemia compensate by raising heart rate and stroke volume.
3. Assess skin for coolness, pallor, cyanosis, diaphoresis, and delayed capillary refill. These reflect diminished circulation and hypoxia. Don't skip the skin and mucous membranes in the rush to the heart and lungs; pallor, jaundice, petechiae, purpura, palmar erythema, and nail defects are easy to miss.
4. Assess for frank bleeding from the nose, gums, vagina, or urinary or GI tract. These are the most common spontaneous bleeding sites, and early detection speeds treatment. Take a careful GI history, since clients often miss the significance of tarry stools.
5. Monitor the platelet count. Thrombocytopenia from marrow malfunction, drugs, viral causes, or aplastic anemia raises bleeding risk. In aplastic anemia, progressive cytopenia hits all three lineages, and platelet and leukocyte counts may fall before hemoglobin.
6. Check stool (guaiac) and urine (Hemastix) for occult blood. These help locate bleeding. Occult GI bleeding presents as a positive fecal occult blood test or iron-deficiency anemia with no visible blood loss.
7. Note changes in level of consciousness, headache, dizziness, or new sensory or motor deficits. These may reflect reduced CNS perfusion from ischemia or infarction. CNS involvement is one of the most devastating parts of sickle cell disease; stroke, usually presenting as hemiparesis, is the most severe manifestation.
8. Assess the lower extremities for skin texture, edema, and ulceration, especially around the ankles. Poor peripheral circulation delays healing. In sickle cell disease, minor injury around the malleoli plus sickling and microinfarcts produces slow-healing leg ulcers that get infected.
9. Evaluate for developing edema. Vaso-occlusion and stasis cause limb edema and, in men, priapism, raising ischemia and necrosis risk. Bilateral edema points to cardiac, renal, or hepatic disease; unilateral edema may signal lymphatic obstruction from malignancy.
10. Consolidate laboratory blood sampling. Repeated draws cause iatrogenic anemia. Switching from conventional to low-volume tubes cuts blood loss by 42%, and consolidating draws minimizes venipunctures and preserves blood volume.
11. Maintain adequate fluid intake. Dehydration causes hypovolemia and, in sickle cell disease, increases sickling and capillary occlusion. Monitor intake and output closely, since these clients are prone to intravascular volume depletion.
12. Maintain body warmth without overheating. Warmth prevents vasoconstriction and supports perfusion, but excess heat causes diaphoresis and insensible losses. Both temperature extremes can precipitate acute sickle cell complications; hypothermia worsens cardiovascular compromise in severe anemia.
13. Monitor labs: CBC, ABGs, liver function, and kidney function. Poor perfusion can infarct organ tissue (brain, liver, spleen, kidney, skeletal muscle) and release intracellular enzymes. Right after blood loss the hematocrit is unreliable because plasma is lost with RBCs; after acute hemorrhage it keeps falling for 24 to 48 hours until plasma volume is replaced.
14. Teach dietary changes to prevent constipation. A high-fiber diet with plenty of fluids, plus stool softeners or laxatives as prescribed, prevents straining. Fiber adds bulk that stimulates defecation; a dietitian can help build a balanced high-fiber plan.
15. Teach bleeding precautions. Start these once the platelet count drops to 50,000 mm3 to prevent spontaneous bleeding. Use an electric shaver instead of a razor and a soft toothbrush to protect the gums. Females may switch to pads, though infection risk is higher with pads than tampons. Avoid rectal suppositories, enemas, and rectal temperatures. Use a water-based lubricant (KY Jelly or Astroglide) during intercourse to reduce friction.
16. Anticipate platelet transfusion when the platelet count falls very low. Platelet replacement reduces bleeding risk; premedicate with antihistamines and antipyretics to limit reactions. Prophylactic transfusion is recommended when platelets fall below 10×10⁹/L, but always guide transfusion by clinical status, not numbers alone.
17. Administer IV fluids such as normal saline via an infusion pump. Hydration lowers hemoglobin concentration and blood viscosity, which reduces sickling and maintains perfusion. Treat a vaso-occlusive crisis with vigorous IV hydration and analgesia, giving enough fluid to correct dehydration and replace insensible and fever-related losses. Normal saline and 5% dextrose in saline may be used.
18. Administer hydroxyurea and watch for serious side effects. Hydroxyurea is a safe, effective treatment for sickle cell disease; it raises total and fetal hemoglobin in children with SCD, and the rise in fetal hemoglobin slows sickling. Clients need frequent monitoring for leukopenia and thrombocytopenia.
19. Administer deferoxamine and vitamin C as prescribed. Chelation corrects the iron overload that comes with regular transfusions, and vitamin C enhances iron excretion in deficient clients. For blood-loss anemia, correct the underlying cause and give oral ferrous sulfate until the anemia resolves and for several months after to replete iron stores.
20. Provide electrolyte replacement as indicated. Sodium and potassium losses climb during crisis from fever, diarrhea, vomiting, and diaphoresis. Potassium can also fall during treatment of severe cobalamin or folate deficiency and lead to sudden death, so potassium supplements may be needed.
21. Teach dietary sources of iron. Iron comes as heme iron in meat and non-heme iron in vegetables and fortified cereals. Ascorbic acid enhances absorption; phytate in legumes, rice, and grains inhibits it.
22. Administer oral anticoagulants as indicated. Monitor closely in clients with high bleeding risk. Low-dose dabigatran reduces bleeding compared with warfarin and may be considered in these clients.
5. Monitoring for Complications
Beyond fatigue, anemia strains multiple organ systems, and the heart takes the biggest hit: low oxygen-carrying capacity drives palpitations, dyspnea, and arrhythmias. Monitor for cardiac and perfusion problems and catch them early.
1. Monitor heart rate, blood pressure, respiratory rate, and oxygen saturation at regular intervals. This detects tachycardia, hypotension, or falling saturation early enough to intervene.
2. Assess for impaired tissue perfusion: delayed wound healing, pallor, cool extremities, cognitive changes. These flag tissue hypoxia so you can act before further complications develop.
3. Run routine labs: CBC, iron studies, and tests specific to the underlying cause. These track hemoglobin and hematocrit, assess iron stores, and gauge response to treatment.
4. Evaluate organ function with renal, hepatic, and other labs as indicated. Anemia is often secondary to chronic conditions that affect organ function, so watch for worsening organ status.
5. Monitor for infection: fever, respiratory changes, localized inflammation, rising WBC count. Anemia weakens immunity, so early detection allows prompt antimicrobial therapy.
6. Teach the client which symptoms to watch for and report: fatigue, dizziness, dyspnea, changes in wound healing, signs of infection. Early reporting lets the team intervene before complications progress.
6. Medications and Pharmacologic Support
Medications target the underlying cause and optimize RBC production. The choice depends on the anemia type, and nurses monitor response (hemoglobin and relevant labs), manage side effects, and teach clients about adverse reactions.
Common medications by anemia type:
1. Iron supplements. For iron-deficiency anemia, to replenish iron stores and support RBC production.
2. Vitamin B12 (injection or oral). For pernicious anemia and other B12 deficiency, to correct the deficiency and promote RBC production.
3. Folic acid supplements. For folic-acid-deficiency anemia, to support RBC synthesis.
4. Erythropoiesis-stimulating agents (ESAs). Erythropoietin or darbepoetin, for anemia of chronic kidney disease or chemotherapy, to stimulate marrow RBC production.
5. Immunosuppressive drugs. For aplastic anemia, to suppress the immune system and limit marrow damage.
6. Corticosteroids. For autoimmune hemolytic anemia and other immune-related anemias, to reduce RBC destruction.
7. Blood transfusions. In severe anemia, packed RBCs quickly restore RBC counts and oxygen-carrying capacity.
7. Laboratory and Diagnostic Procedures
Tracking labs lets you gauge severity, identify the cause, follow the response to treatment, and catch complications early.
Laboratory studies:
1. Complete Blood Count (CBC). Measures hemoglobin, hematocrit, RBC count, WBC count, and platelet count.
2. Peripheral Blood Smear. Microscopic look at the size, shape, and appearance of red cells, white cells, and platelets.
3. Reticulocyte Count. The percentage of reticulocytes (immature RBCs), showing the marrow's ability to make new red cells.
4. Serum Iron, Ferritin, and Transferrin Saturation. Measures iron levels and stores, especially in iron-deficiency anemia.
5. Vitamin B12 and Folic Acid Levels. Assesses deficiencies that cause anemia.
6. Erythropoietin Level. Measures the hormone that stimulates RBC production, useful in kidney-related anemia.
7. Coagulation Studies. Assesses clotting and evaluates bleeding disorders that contribute to anemia.
Diagnostic procedures:
8. Bone Marrow Aspiration and Biopsy. Samples marrow to assess cellular composition, RBC production capacity, and any abnormalities.
9. Upper and Lower Endoscopy. Visualizes the GI tract to find sources of bleeding.
10. Imaging Studies (ultrasound, CT, MRI). Evaluates organs and tissues for abnormalities or bleeding sources.
11. Genetic Testing. Identifies inherited disorders such as thalassemia or sickle cell disease when indicated.
Frequently Asked Questions
What hemoglobin level counts as anemia? The WHO 2024 guideline defines anemia as a hemoglobin under 13 g/dL in men and under 12 g/dL in non-pregnant women. You confirm and quantify it with the RBC count, hemoglobin, and hematocrit, then classify it by the corrected reticulocyte count and mean corpuscular volume.
Is anemia a diagnosis? No, it is a sign, not a diagnosis. NHLBI notes there are three basic causes: blood loss, increased red cell destruction, and decreased red cell production. The team has to find and treat the underlying cause; correcting the number alone is not enough.
What are the nursing priorities for an anemic patient? Protect oxygen delivery, pace activity against fatigue, catch bleeding early, and run transfusions and supplements safely while the cause is worked up. Fatigue is the most common and most underrated symptom, so take it seriously even when the anemia is mild.
How much does one unit of packed red blood cells raise hemoglobin? About 1 g/dL per unit. Reserve transfusion for active bleeding or severe symptomatic anemia; it is palliative and not a substitute for specific therapy, and it carries risks of hemolytic reaction and infection transmission.
Why is infection a concern in anemia? Adequate iron supports the proliferation and maturation of immune cells, and many anemic patients (especially those with aplastic anemia or on immunosuppression) are immunocompromised. Monitor the WBC count, watch for fever and chills, and use protective isolation when the absolute neutrophil count is very low.
How is iron-deficiency anemia treated nutritionally? Increase iron intake and absorption. Heme iron from meat absorbs more efficiently than non-heme iron from plants. Give oral iron with vitamin C to boost absorption, and limit tea or coffee with doses since they reduce it. Teach iron-rich foods such as green leafy vegetables, red meat, tofu, raisins, and dates.